← All stocks

ALNYLAM PHARMACEUTICALS, INC.

ALNY No buying or selling

CIK 0001178670 #636 in the set updated 18 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

20 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Greenstreet Yvonne

Chief Executive Officer

—

95,695

$28.96M

+30.3%

Poulton Jeffrey V.

EVP, Chief Financial Officer

—

61,805

$18.71M

+113.9%

Tanguler Tolga

EVP, Chief Commercial Officer

—

34,297

$10.38M

+194.1%

SCHULMAN AMY W

Director

—

24,049

$7.28M

+185.1%

Fitzgerald Kevin Joseph

CSO & EVP, Head of Research

—

20,569

$6.23M

+59.7%

Garg Pushkal

EVP Chief R&D

—

18,693

$5.66M

+19.8%

BONNEY MICHAEL W

Director

—

16,804

$5.09M

+4.8%

SUPRAN BRYAN

EVP, CLO and Secretary

—

14,565

$4.41M

—

McLaughlin Melissa

Chief Human Resources Officer

—

9,443

$2.86M

−29.3%

Hesslein Robert W.

EVP, CLO and Secretary

—

8,002

$2.42M

—

PYOTT DAVID E I

Director

—

1,582

$478.79K

+1,063%

HAMBURG MARGARET A

Director

—

1,582

$478.79K

+1,063%

Ausiello Dennis A

Director

—

1,582

$478.79K

+1,063%

BRANDICOURT OLIVIER

Director

—

1,446

$437.63K

—

Sigal Charles Elliott

Director

—

1,446

$437.63K

—

Reitan Colleen F

Director

—

1,446

$437.63K

+4,419%

KELLOGG PETER N

Director

—

1,446

$437.63K

—

Bertozzi Carolyn R

Director

—

775

$234.55K

—

Arbuckle Stuart A

Director

—

671

$203.08K

—

SHARP PHILLIP A

Director

—

$0.00

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

ALNYLAM PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out